Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]
about
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signalingVascular endothelial growth factor can signal through platelet-derived growth factor receptorsSelective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreadingThe vascular endothelial growth factor (VEGF) family: angiogenic factors in health and diseasePathways for aberrant angiogenesis in pancreatic cancerInfluence of hypoxia and neoangiogenesis on the growth of pancreatic cancerNRP1 function and targeting in neurovascular development and eye diseaseNeuropilins: expression and roles in the epitheliumExtracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Vascular endothelial growth factor-B in physiology and diseasePharmacological aspects of Vipera xantina palestinae venomThe crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolutionStructural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF bindingA model for gene therapy of human hereditary lymphedemaPLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesisSelective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastomaA perspective on the role of class III semaphorin signaling in central nervous system traumaAngiomotin regulates endothelial cell migration during embryonic angiogenesisThe cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veinsVEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vesselsPlacental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disordersIdentification and characterization of a novel member of murine semaphorin familyA peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cellsGeneChip analysis of human embryonic stem cell differentiation into hemangioblasts: an in silico dissection of mixed phenotypes.Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain.Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1.Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cellsIGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangiomaThe VEGF family in cancer and antibody-based strategies for their inhibition.RanBPM contributes to Semaphorin3A signaling through plexin-A receptors.Reduced vascular endothelial growth factor expression in contusive spinal cord injury.Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesisPharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.Molecular diversity of VEGF-A as a regulator of its biological activity.Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.
P2860
Q24296700-0819245C-8DB9-45A4-8E7F-F9FAF8E724A7Q24304294-4084B41D-86B7-4E9E-A750-966737D4C089Q24531302-39A8AF8E-AD09-4AC1-B01E-7DEC9844E5D2Q24550908-3C0E061C-ACF7-43F3-AE78-92CFD290DF41Q24796165-2E0255F2-AEF7-4147-9C65-1C161130C834Q24800215-4BB6DA6E-CE70-4C75-8842-558457A40D17Q24801511-361DFECC-A808-45D6-9FD0-4D7D4F7F31E2Q26765952-947457FC-4E36-4605-92AB-0E53C1E1061AQ26998786-AFFD789F-F2C6-4B93-90FA-75410F2ADFFFQ27000351-7E1140E9-29D5-43DC-BDCE-53D5AD5BB3DDQ27003400-DE7ACC88-345B-47E7-B5FC-4CAF25B687C3Q27005573-D72A7CEA-2C95-414F-AC88-84970A5107D0Q27628017-EE016BCE-5A37-4AA1-B027-B9241DF15B46Q27648978-1ECCBB97-E2F9-4CFB-AB4E-10D909CE10C4Q28191040-D3697640-EAB0-4DEB-A8A9-6D980EB43CF1Q28212775-0FD61702-9E4E-4864-9DF5-24F0F501AAAEQ28216873-9AC47720-DC24-4C5B-B65C-45C33BF89D56Q28251368-B3C496E4-0FAA-4381-A5D4-3F77DB6BBAFDQ28586167-6E591DD0-BF7A-4BAF-87F1-DFE4E0BC024CQ28590445-54AEDE60-B272-477B-8CFA-4EE6A192D9C0Q28593860-B5BC7137-5787-4DFD-AB08-7C7D0D6FA5CEQ28646428-FC0BE305-1C71-4EB5-B43E-FE0FE3AE584BQ28941241-5F6B76A1-D1D6-45EA-94AA-4B5D071CFB55Q29543360-1524143D-3605-41CB-952F-7DC31ACCFFD9Q30481349-31AF631C-2F2B-4218-BF9B-562AFD14533EQ31088312-59EF23BC-1946-43CA-A631-85403C0CD989Q31131003-22CF89D2-73FC-4F04-9E5F-E669F2CAFD06Q31518636-0FC3FB8D-B925-43AC-A439-F312EDC295F6Q33372124-A5F7B7BA-6A7B-425F-9A89-06E2DAA7E154Q33607333-07BCFB0B-EB9D-4CBB-887A-BA5D87484C38Q33733437-F6FA5BD2-36D6-412F-9BEE-0CC22DC453C3Q33756397-5E1B0A07-DAFA-4213-8230-3B3126B6F7E3Q33767262-78026ED8-1243-48C5-87FE-8C85057E39A7Q33940345-7A6418D1-9D53-4C9D-A0AE-5866D21D41DBQ34019593-5A55DE1D-EBB2-48BF-AC18-C1A43BD2A4BAQ34079689-9CB511D0-3D8E-42C2-92FB-2FDAB3581769Q34089123-0D4924B6-93F9-489B-BC3A-A04CC557E647Q34147572-D67B1D77-F608-4192-9597-96F371F2B3C0Q34157370-BF138B63-CB4C-4653-86F9-61BA997654D0Q34343895-00D54B25-92E7-4FED-BC1A-BB161795F7AD
P2860
Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@ast
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@en
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@nl
type
label
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@ast
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@en
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@nl
prefLabel
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@ast
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@en
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@nl
P2093
P356
P1476
Neuropilin-2 is a receptor for ...... F-145 and VEGF-165 [corrected]
@en
P2093
Z Gluzman-Poltorak
P304
P356
10.1074/JBC.M909259199
P407
P577
2000-06-16T00:00:00Z